Comparison of a dengue-2 virus and its candidate vaccine derivative: sequence relationships with the flaviviruses and other viruses.Blok J., McWilliam S.M., Butler H.C., Gibbs A.J., Weiller G., Herring B.L., Hemsley A.C., Aaskov J.G., Yoksan S., Bhamarapravati N.View abstractCited forNUCLEOTIDE SEQUENCE [GENOMIC RNA]CategoriesSequencesSourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCVirology 187:573-590 (1992)Cited in2
Dengue virus non-structural protein 1 modulates infectious particle production via interaction with the structural proteins.Scaturro P., Cortese M., Chatel-Chaix L., Fischl W., Bartenschlager R.View abstractCited forFUNCTION (NON-STRUCTURAL PROTEIN 1)CategoriesFunctionSourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCPLoS Pathog. 11:E1005277-E1005277 (2015)Cited in2
Flaviviruses Exploit the Lipid Droplet Protein AUP1 to Trigger Lipophagy and Drive Virus Production.Zhang J., Lan Y., Li M.Y., Lamers M.M., Fusade-Boyer M., Klemm E., Thiele C., Ashour J., Sanyal S.View abstractCited forFUNCTION (NON-STRUCTURAL PROTEIN 4A), INTERACTION WITH HUMAN AUP1 (NON-STRUCTURAL PROTEIN 4A)CategoriesFunction, InteractionSourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCCell Host Microbe 23:819-831.e5 (2018)Cited in2
Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins.Lok S.M., Kostyuchenko V., Nybakken G.E., Holdaway H.A., Battisti A.J., Sukupolvi-Petty S., Sedlak D., Fremont D.H., Chipman P.R.[...], Rossmann M.G.View abstractCited forX-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 578-674CategoriesStructureSourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCNat. Struct. Mol. Biol. 15:312-317 (2008)Cited in32Mapped to2
Analysis of flavivirus NS5 methyltransferase cap binding.Geiss B.J., Thompson A.A., Andrews A.J., Sons R.L., Gari H.H., Keenan S.M., Peersen O.B.View abstractCited forX-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 2493-2757CategoriesStructureSourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCJ. Mol. Biol. 385:1643-1654 (2009)Cited in2
Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virus.Renner M., Flanagan A., Dejnirattisai W., Puttikhunt C., Kasinrerk W., Supasa P., Wongwiwat W., Chawansuntati K., Duangchinda T.[...], Grimes J.M.View abstractCategoriesStructureSourcePDB: 6FLAPubMedEurope PMCNat Immunol 19:1248-1256 (2018)Cited in1Mapped to2
Viral immune modulators perturb the human molecular network by common and unique strategies.Pichlmair A., Kandasamy K., Alvisi G., Mulhern O., Sacco R., Habjan M., Binder M., Stefanovic A., Eberle C.A.[...], Superti-Furga G.View abstractCategoriesInteractionSourceIntAct: P29991PubMedEurope PMCNature 487:486-490 (2012)Mapped to99+